Pharmaceuticals

Global Menopausal Disorder Treatment Market Overview: Trends Shaping Growth to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Menopausal Disorder Treatment Industry In 2025?

The market for treating menopausal disorders has demonstrated substantial growth in recent years. This market is projected to expand from $10.69 billion in 2024 to $11.47 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.3%. The historical expansion is a result of several contributing factors, including an aging female demographic, greater understanding of health issues linked to menopause, the widespread occurrence of obesity making menopausal symptoms worse, rising adoption of hormone replacement therapy (HRT), and advancements in personalized medicine.

The menopausal disorder treatment market is projected to experience robust expansion over the next few years. This market is set to reach $15.2 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth during the forecast period is attributable to increasing investment in healthcare infrastructure, a heightened emphasis on women’s health programs, more frequent collaborations between pharmaceutical companies and research institutions, and rising urbanization contributing to lifestyle changes that impact menopausal health. Key trends in the upcoming period include a shift toward natural and herbal remedies, the integration of artificial intelligence into treatment planning, the emergence of wearable devices for real-time symptom tracking, a focus on holistic wellness programs addressing menopause, and increased funding for women’s health startups developing menopause solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

What Are The Drivers Pushing New Developments In The Menopausal Disorder Treatment Market?

The increasing need for hormone replacement therapies (HRT) is anticipated to drive the expansion of the menopausal disorder treatment market in the future. HRT is defined as a medical approach where hormones are supplemented or substituted to ease symptoms linked to menopause or hormonal imbalances. The uptake of hormone replacement therapies is fueled by heightened awareness and a desire for effective management of menopausal symptoms and hormonal irregularities. HRT addresses menopausal disorder by directly restoring estrogen and progesterone levels, thus assisting in re-establishing hormonal equilibrium and mitigating bothersome symptoms like hot flashes, night sweats, and mood swings, which ultimately enhances the quality of life. As an example, the NHS Business Services Authority (NHSBSA), a UK support services organization, stated in October 2024 that HRT prescriptions increased by 22% to 13 million, alongside a 12% rise in identified patients, moving from 2.3 million in 2022/23 to 2.6 million in 2023/24. Consequently, the escalating demand for hormone replacement therapies is propelling the growth of the menopausal disorder treatment market.

What Are The Major Segment Types Covered In The Menopausal Disorder Treatment Market?

The menopausal disorder treatment market covered in this report is segmented –

1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications

2) By Stages: Menopause, Postmenopause, Perimenopause

3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets

2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements

3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed

4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

Which Trends Are Impacting The Menopausal Disorder Treatment Market?

Leading companies in the menopausal disorder treatment market are developing new nonhormonal neurokinin 3 (NK3) receptor antagonist drugs to effectively alleviate vasomotor symptoms without relying on hormone therapy. These innovative nonhormonal neurokinin 3 (NK3) receptor antagonist therapies are novel treatments that work by blocking NK3 receptors to manage menopausal symptoms without using hormones. For instance, in December 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, secured European Commission approval for Veozah (fezolinetant). This non-hormonal NK3 receptor antagonist is designed for treating moderate to severe vasomotor symptoms (VMS), such as hot flashes and night sweats, in menopausal women. Its action involves targeting neurons within the brain’s temperature control center to diminish the frequency and intensity of these symptoms.

Which Key Market Players Are Investing In Expansion And Innovation Of Menopausal Disorder Treatment Market?

Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

What Are The Regional Market Dynamics Impacting The Menopausal Disorder Treatment Industry?

North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Menopausal Disorder Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24318&type=smp

Browse Through More Reports Similar to the Global Menopausal Disorder Treatment Market 2025, By The Business Research Company

Menopausal Hot Flashes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report

Postmenopausal Osteoporosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/postmenopausal-osteoporosis-treatment-global-market-report

Vasomotor Menopausal Symptoms Vms Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vasomotor-menopausal-symptoms-vms-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795